ACR24 - JAK_TYK2
Rheumnow Podcast
Evaluating the Safety of JAK Inhibitors in Treatment
This chapter examines the safety profile of JAK inhibitors in treating conditions such as atopic dermatitis and juvenile idiopathic arthritis. It highlights crucial findings from the oral surveillance study and the significance of ongoing safety monitoring while expressing optimism for their continued approval and usage in broader treatment protocols.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
